Suchergebnisse - (Subject:"*Disease Progression")

PubPharm (6.537)

61

Treatment of autoimmune hepatitis-First-line, second-line and third-line treatment

enthalten in: Innere Medizin (Heidelberg, Germany) | 2024

von Taubert, R. | Engel, B.

62

Enhancing RECK Expression Through miR-21 Inhibition : A Promising Strategy for Bladder Carcinoma Control

enthalten in: Biochemical genetics | 2024

von Dos Santos, P. | da Silva Gomes, P. | Romão, P. | +12

63

The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors

enthalten in: Journal of robotic surgery | 2024

von Porcaro, A. | Orlando, R. | Panunzio, A. | +17

64

The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors

enthalten in: Journal of robotic surgery | 2024

von Porcaro, A. | Orlando, R. | Panunzio, A. | +17

65

Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome : A Prospective and Retrospective Observational/Non-interventional Study to Characterize Biomarkers and Disease Progression in Patients With MECP2 Duplication Syndrome

enthalten in: ClinicalTrials.gov | 2024

66

Plasmapheresis Versus Plasma Infusion From Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression : Plasmapheresis Versus Plasma Infusion From Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression: An Unblinded Phase 1 Safety, Methodological and Exploratory Biomarkers Study.

enthalten in: ClinicalTrials.gov | 2024

67

Hidradenitis suppurativa

enthalten in: Dermatologie (Heidelberg, Germany) | 2024

von Alter, M.

68

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD : Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic Interstitial Lung Disease

enthalten in: ClinicalTrials.gov | 2024

69

Mindfulness-based Interventions in COPD Patients : A Pilot Randomized Controlled Trial to Examine the Feasibility and Effectiveness of a Brief Digital Mindfulness-based Intervention for COPD Patients

enthalten in: ClinicalTrials.gov | 2024

70

Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies

enthalten in: medRxiv : the preprint server for health sciences | 2024

von Scotton, W. | Shand, C. | Todd, E. | +14